In the case of brand name drugs versus generics, patents can be bad medicine, WVU law professor says
Sean Tu with the West Virginia University College of Law is researching ways brand name firms manipulate the patent system to improperly maintain monopoly rights on pharmaceuticals, moves that potentially affect patient welfare.